| |
  
Post-Activity Survey and Evaluation
The Promise of Gene Therapy: Access and Coverage for Innovative, High-Cost Treatments
|
In an effort to better determine the overall effectiveness of continuing education activities, we are conducting a brief survey. Listed below are questions for which we would like your responses. All information obtained will be used and reported in aggregate only, without individual attribution. Thank you for your participation.
If you have any questions please contact us at info@impactedu.net.
*All questions are required.
|
|
Q1.1
|
Now that you have participated in this activity, how confident are you in your ability to distinguish innovative approaches that have been proposed for the funding and coverage of emerging high-cost therapies?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.2
|
What conditions represent the second leading disease area (i.e., other than cancer) in terms of gene therapy research and development?
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.3
|
Which potential strategy for the funding and coverage of gene therapy is a specialized approach that allows for more effective and efficient care?
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.4
|
Now that you have participated in this activity, how confident are you in your ability to evaluate results from gene therapy trials for the treatment of hemophilia?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.5
|
Within your plan or practice setting when applicable, how often do you plan to consider your current organization’s environment and characteristics when assessing innovative access schemes for gene therapies? (1 = Never, 6 = Always)
(Please select the appropriate number on the scale below or mark if this decision or authority is outside your usual scope of practice)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Evaluation Form
Medical Education Resources, Inc. is committed to excellence in continuing education, and your opinions are critical to us in this effort. To assist us in evaluating the effectiveness of this activity and to make recommendations for future educational offerings, please take a few minutes to complete this evaluation form.
You must complete this evaluation form to receive acknowledgment for completing this activity.
|
|
Q1.6
|
What is your specialty?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.7
|
What best describes your primary role?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.8
|
How many years have you been in your area of responsibility?
|
|
|
|
|
|
|
|
|
|
|
Q1.9
|
Approximately how many patients with hemophilia are being managed in your organization, practice setting, or affiliated organizations?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.14
|
Based upon your participation in this activity, do you intend to change your practice and/or administrative behavior?
|
|
|
|
|
|
|
|
|
|
Q1.16
|
If you plan to change your practice and/or administrative behavior, what type of changes do you plan to implement?
(check all that apply)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.17
|
How confident are you that you will be able to make your intended changes?
|
|
|
|
|
|
|
|
|
|
|
|
Q1.18
|
Which of the following do you anticipate will be the primary barrier to implementing these changes?
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1.19
|
Was the content of this activity fair, balanced, objective, and free of commercial bias?
|
|
|
|
|
|
|
|
Q1.31
|
TO CLAIM CREDIT: Upon submission of your evaluation you will be redirected to a web page with instructions. You must follow the instructions to claim credit. Submission of the evaluation alone will not provide credit.
|
|
|
|
|
If you have any questions please email info@impactedu.net.
|
| |